SCHEMBL4735688

SCHEMBL4735688

CC(C)OC(=O)c1ccccc1C(=O)c1ccccc1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.56
CRHR2 Q13324 1/20 0.56
ALDH1A1 P00352 9/20 0.51
HSD17B10 Q99714 7/20 0.51
CFTR P13569 1/20 0.51
NPC1 O15118 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
TSHR P16473 2/20 0.44
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
CA12 O43570 3/20 0.43
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA7 P43166 3/20 0.43
CA9 Q16790 3/20 0.43
CA14 Q9ULX7 3/20 0.43
KDM4E B2RXH2 4/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29979726 0.90 ALDH1A1 (0.63) CRHBPCRHR2ALDH1A1HSD17B10CFTR
SCHEMBL3507300 0.90 ALDH1A1 (0.63) CRHBPCRHR2ALDH1A1HSD17B10CFTR
SCHEMBL137907 0.84 NPC1 (0.62) CRHBPCRHR2ALDH1A1HSD17B10NPC1
SCHEMBL399125 0.80 NPC1 (0.56) CRHBPCRHR2ALDH1A1HSD17B10CFTR
SCHEMBL12792953 0.80 HSD17B10 (0.45) CRHBPCRHR2ALDH1A1HSD17B10CFTR
SCHEMBL8764887 0.80 MAPT (0.71) ALDH1A1HSD17B10CFTRNPC1GAA
SCHEMBL2929420 0.79 NPC1 (0.51) CRHBPCRHR2ALDH1A1HSD17B10CFTR
SCHEMBL9456728 0.79 CRHBP (0.56) CRHBPCRHR2ALDH1A1NPC1GAA
SCHEMBL22164112 0.78 NPC1 (0.57) CRHBPCRHR2ALDH1A1HSD17B10NPC1
SCHEMBL30790667 0.78 MAPT (0.74) ALDH1A1HSD17B10CFTRNPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008060844-A1 POLYMERIZATION INHIBITOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE ALBEMARLE CORPORATION (US) 2008-05-22 WO disclosed